Back to Companies
Cogent Biosciences, Inc.
COGTNasdaqCIK: 0001622229
Recent Form 4 activity at Cogent Biosciences, Inc. (COGT) spans 8 filings across 4 insiders (all of them on the sell side). Purchases total $25.0M against $370.0M in sales — heavily weighted toward selling, for net sales of $345.0M. Fairmount Funds Management LLC (Director) is the most active by dollar volume, and the single largest transaction was $242.6M by Fairmount Funds Management LLC. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$396.8M
Purchases
$25.0M
Sales
$370.0M
Unique Insiders
4
Recent Insider Trades
8 loaded
| Jul 6 | COGT Cogent Biosciences, Inc. | Ferrante Karen Jean | Insider | Award | $24.1K |
| Jun 11 | COGT Cogent Biosciences, Inc. | Ferrante Karen Jean | Insider | Award | $572.5K |
| Jun 11 | COGT Cogent Biosciences, Inc. | Harwin Peter Evan | Insider | Award | $572.5K |
| Jun 11 | COGT Cogent Biosciences, Inc. | CAIN CHRISTOPHER W. | Insider | Award | $572.5K |
| Mar 31 | COGT Cogent Biosciences, Inc. | Fairmount Funds Management LLC | Director | Sell | $242.6M |
| Jan 22 | COGT Cogent Biosciences, Inc. | Fairmount Funds Management LLC | Director | Sell | $127.4M |
| Oct 3 | COGT Cogent Biosciences, Inc. | Ferrante Karen Jean | Insider | Award | $23.2K |
| Jul 14 | COGT Cogent Biosciences, Inc. | Fairmount Funds Management LLC | Director | Buy | $25.0M |
8 filings